Safety Considerations with Bisphosphonates for the Treatment of Osteoporosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference52 articles.
1. Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
2. Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
3. Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal OsteoporosisA Randomized Controlled Trial
4. New Insights Into the Molecular Mechanisms of Action of Bisphosphonates
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause;Expert Opinion on Pharmacotherapy;2024-07-02
2. Quercetin in Osteoporosis Treatment: A Comprehensive Review of Its Mechanisms and Therapeutic Potential;Current Osteoporosis Reports;2024-04-23
3. Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study;Osteoporosis International;2024-01-10
4. Development of 3-acetylindole derivatives that selectively target BRPF1 as new inhibitors of receptor activator of NF-κB ligand (RANKL)-Induced osteoclastogenesis;Bioorganic & Medicinal Chemistry;2023-12
5. Using network pharmacology and molecular docking verification to explore the mechanism of ursolic acid in the treatment of osteoporosis;Medicine;2022-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3